EICHOR
● Not Yet Recruiting
Treatment for Ph-negative ALL for Adults up to 65 Years
Condition: Acute Lymphoblastic Leukemia · Sponsor: PETHEMA Foundation
About this study
The goal of this trial is to provide a protocol for treatment for adults with Ph-negative acute lymphoblastic leukemia (ALL) and to learn if this provides higher probability of survival than the previous one. The main question is to know if the incorporation of blinatumomab for B-cell precursor ALL, substituting some chemotherapy blocks, offers better probability of survival than the previous trial, which did not use immunotherapy. In addition, T-cell precursor ALL participants will receive different treatment approaches depending on the stage of maturation of the tumor.
This description comes directly from the study's public registry record.
Talk to the study team
Anna Torrent, Dr · +34934978987 · atorrent@iconcologia.net
Josep Maria Ribera · +34934978987 · jribera@iconcologia.net
Always discuss trial participation with your own doctor first.
Locations (95)
| Hospital de A Coruña | A Coruña, Spain | — |
| Hospital Universitario de Araba | Alava, Spain | — |
| Hospital General Universitario de Albacete | Albacete, Spain | — |
| Hospital General Universitario Dr. Balmis | Alicante, Spain | — |
| Hospital Universitario Torrecárdenas | Almería, Spain | — |
| Hospital General de Lanzarote | Arrecife, Spain | — |
| Hospital Nuestra Señora de Sonsoles / Complejo Asistencial de Ávila | Ávila, Spain | — |
| Hospital Universitario de Badajoz | Badajoz, Spain | — |
| ICO-Hospital Germans Trias i Pujol | Badalona, Spain | — |
| Hospital Clínic de Barcelona | Barcelona, Spain | — |
| Hospital de Sant Pau | Barcelona, Spain | — |
| Hospital del Mar | Barcelona, Spain | — |
+ 83 more locations — full list on the registry record.
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07443592